With the new funding, Quanta plans to conduct research on portable dialysis equipment used by its families.This startup based in Alcester, UK won Food and Drug Administration in December Used for its equipment in hospitals or post-acute environments.
It is one of several companies hoping to enter the home dialysis market, such as established companies such as DaVita, CVS Health and Fresenius Medical Care Hope to expand their home products.
Although home dialysis can make patients with chronic kidney disease spend hours in the dialysis center every week, it still requires some training and support. The patient even knows this is an option.
Quanta recently raised US$245 million in a Series D financing led by Glenview Capital and Novo Holdings. In view of the recent approval, it plans to use the funds to expand its business, with a focus on the United States. Part of the funds will also be used for a study that the company hopes to use to support household licenses for the device.
“We are very happy to attract such a strong investor consortium, which represents a clear trust in our innovative approach to dialysis treatment,” CEO John Millard said in a press conference. “Everyone knows that dialysis care must be improved. For this, providers and doctors need products with greater flexibility that can bring dialysis directly to patients, while simplifying complexity and reducing overall care costs.”
Other equipment competitors are also seeking to further advance home dialysis.Last year, in San Jose Starting point medical listing, After obtaining FDA approval to use its equipment at home.
Photo: aurielaki, Getty Images